/
/
/
Antibacterial and Anticancer Activity of Stromatic Xylaria spp. from Tropical Forest Thailand

Antibacterial and Anticancer Activity of Stromatic Xylaria Spp. From Tropical Forest Thailand

Original Research ArticleJan 5, 2018Vol. 15 No. 1 (2015)

Abstract

This research is part of a bioactive metabolite study of fungi collected from Trat Agroforestry Training Station, Trat province, Thailand. The ultimate goal is to screen for bioactivity, including those exhibiting antibacterial and anticancer, activity from isolates of stromatic Xylaria spp. Fresh specimens of Xylaria spp. were cultured on Potato Dextrose Agar (PDA) for 14 days, and then transferred to Malt Extract Broth (MEB). All isolations were cultured under static conditions for 6 weeks and extracted with ethyl acetate and concentrated by evaporation. All crude extracts were tested for antimicrobial activities against 4 pathogenic microorganisms, including Gram-positive bacteria (Staphylococcus aureus and Bacillus subtilis), and Gram-negative bacteria (Pseudomonas aeruginosa and Escherichia coli), in terms of MIC values. Anticancer activity against 5 human cell lines was measured by MTT colorimetric assay. The results showed that all crude extracts inhibited at least 1 tested microorganism. Ten of the extracts showed a broad spectrum of action against the test bacteria. Selected Xylaria isolates were chosen for examination of their anticancer activity. Isolate TR 25 showed the highest cytotoxicity; this was against KATO-III cell line with a IC50 value of 7.8 µg.mL-1.

 Keywords: Xylaria, stromata, bioactive metabolites, antimicrobial, anticancer

*Corresponding author: Tel.: + 662-2185070

   E-mail: sprakits@chula.ac.th, okriattapong@gmail.com

How to Cite

Orachaipunlap, K. ., Suwannasai, N. ., Whalley, A. J. ., Roengsumran, S. ., & Sihanonth*, P. . (2018). Antibacterial and Anticancer Activity of Stromatic Xylaria spp. from Tropical Forest Thailand. CURRENT APPLIED SCIENCE AND TECHNOLOGY, 1-9.

References

  • Cragg, G.M., Kingston, D.G.I., Newman, D.J., (Eds.), 2005. Anticancer Agents from Natural Products. Brunner-Routledge Psychology Press, Taylor & Francis Group, Boca Raton.
  • Newman, D.J., Cragg, G.M., Snader, K.M., 2003. Natural products as sources of new drugs over the period, Journal of Natural Products. 66, 1022-1037.
  • Hawksworth, D.L., 2001. The magnitude of fungal diversity: The 1.5 million species estimate revisited. Mycological Research 105, 1422-1432.
  • Hawksworth, D.L., and Rossman, A.Y., 1997 .Where are all the undescribed fungi?. Phytopathology. 87, 888-891.
  • Rossman, A., 1994. A strategy for an all-taxa inventory of fungal biodiversity.In C. I. Peng and C.H. Chou [eds.], Biodiversity and terrestrialecosystems, 169-194. Academia Sinica Monograph Series 14, Taipei, Taiwan.

Author Information

Krittapong Orachaipunlap

Program of Biotechnology, Faculty of science, Chulalongkorn University, Bangkok, Thailand

Nuttika Suwannasai

Departments of Biology, Srinakharinwirot University, Bangkok, Thailand

Antony J. Whalley

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom

Sophon Roengsumran

Departments of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand

Prakitsin Sihanonth*

Departments of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok,Thailand

About this Article

Journal

Vol. 15 No. 1 (2015)

Type of Manuscript

Original Research Article

Keywords

Xylaria, stromata, bioactive metabolites, antimicrobial, anticancer

Published

5 January 2018